Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in Working CapitalDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonDividends Paid - PreferredFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Change in Accured Expenses: 2009-2025

Historic Change in Accured Expenses for Amdocs (DOX) over the last 13 years, with Sep 2025 value amounting to $8.5 million.

  • Amdocs' Change in Accured Expenses fell 90.63% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$344.2 million, marking a year-over-year decrease of 259.11%. This contributed to the annual value of -$77.0 million for FY2025, which is 135.61% down from last year.
  • As of Q3 2025, Amdocs' Change in Accured Expenses stood at $8.5 million, which was down 79.20% from $41.1 million recorded in Q2 2025.
  • In the past 5 years, Amdocs' Change in Accured Expenses ranged from a high of $147.5 million in Q2 2023 and a low of -$343.0 million during Q1 2025.
  • Over the past 3 years, Amdocs' median Change in Accured Expenses value was $41.1 million (recorded in 2025), while the average stood at -$4.6 million.
  • In the last 5 years, Amdocs' Change in Accured Expenses spiked by 2,790.34% in 2022 and then slumped by 1,234.00% in 2025.
  • Quarterly analysis of 5 years shows Amdocs' Change in Accured Expenses stood at -$3.1 million in 2021, then skyrocketed by 2,790.34% to $82.1 million in 2022, then climbed by 16.62% to $95.8 million in 2023, then tumbled by 153.07% to -$50.8 million in 2024, then plummeted by 90.63% to $8.5 million in 2025.
  • Its Change in Accured Expenses stands at $8.5 million for Q3 2025, versus $41.1 million for Q2 2025 and -$343.0 million for Q1 2025.